(RTTNews) - Biogen Inc. (BIIB) announced Wednesday the recent initiation of the Phase 2 clinical trial AFFINITY, designed to evaluate opicinumab as an investigational add-on therapy in people with ...
BASKING RIDGE, N.J., January 12, 2026--(BUSINESS WIRE)--Affinity Federal Credit Union ("Affinity") is proud to announce a series of prestigious awards and recognitions received in 2025. The ...
Affinity MSP ranks as Australia's top IT managed service provider and 69th globally on the prestigious 2026 MSP 501 ranking list.Melbourne, ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen (NASDAQ: BIIB) announced today the recent initiation of the Phase 2 clinical trial AFFINITY, designed to evaluate opicinumab as an investigational add-on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results